AE Wealth Management’s Neuronetics STIM Stock Holding History
Bought
Maintained
Sold
Other funds holding STIM
CC
ACM
SAM
KLC
MAG
BGIM
AE Wealth Management's STIM Position: Q1 2023 in Review
AE Wealth Management sold out of Neuronetics (STIM) in Q1 2023, closing a stake of 12,796 shares — an estimated $87.9K sold.
AE Wealth Management first reported a position in STIM in Q4 2022 and held it in 1 quarter. The position peaked at $87.9K in Q4 2022. 74 funds tracked by Wall St. Rank hold STIM as of Q1 2023.
- AE Wealth Management reported no remaining Neuronetics position as of Q1 2023 after selling out during the quarter.
- AE Wealth Management sold 12,796 Neuronetics shares in Q1 2023, an estimated $87.9K.
- AE Wealth Management first reported a position in Neuronetics in Q4 2022 and held it in 1 quarter.
- AE Wealth Management's Neuronetics position peaked at $87.9K in Q4 2022.
- 74 funds tracked by Wall St. Rank held Neuronetics as of Q1 2023.
Based on AE Wealth Management's 13F filing for Q1 2023, filed 14 Apr 2023.